Inogen, Inc.

NASDAQ:INGN

Medical - Devices

Healthcare
$5.42 +0.71%

+$0.05 today

Market cap
$140.93M
Beta
1.60
P/E (TTM)
-7.0
EPS (TTM)
-$0.91
52W Low $5.34High $9.13

Volume 0.22M

Average 0.33M

Income Statement

Follow revenue through to earnings.

Revenue

$348.67M

FY 2025 · Annual

+3.9% YoY

Operating Income

-$30.21M

FY 2025 · Annual

Net Income

-$22.75M

FY 2025 · Annual

Income Statement

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Revenue358M377.24M315.66M335.71M348.67M
Cost of Revenue181.52M223.71M188.96M180.96M182.78M
Gross Profit176.48M153.53M126.7M154.74M165.89M
Gross Margin49.3%40.7%40.1%46.1%47.6%
Research & Development16.58M21.94M20.84M21.61M19.4M
Selling, General & Admin150.67M164.67M182.35M175.65M165.07M
Operating Expenses167.24M238.78M236.09M197.26M196.1M
Depreciation & Amortization21.63M23.51M18.15M21M20.66M
EBITDA30.29M(9.57M)(58.34M)(15.47M)(2.72M)
EBITDA Margin8.5%-2.5%-18.5%-4.6%-0.8%
Operating Income9.24M(85.24M)(109.39M)(42.52M)(30.21M)
Operating Margin2.6%-22.6%-34.7%-12.7%-8.7%
Interest Income129K2.84M6.57M5.19M2.15M
Interest Expense00000
Other Income / Expenses(581K)1.98M7.04M6.04M6.83M
Income Before Tax8.66M(83.27M)(102.34M)(36.48M)(23.38M)
Pre-Tax Margin2.4%-22.1%-32.4%-10.9%-6.7%
Income Tax Expense14.99M504K105K(588K)(632K)
Net Income(6.33M)(83.77M)(102.45M)(35.89M)(22.75M)
Net Margin-1.8%-22.2%-32.5%-10.7%-6.5%
EPS (Basic)(0.28)(3.67)(4.42)(1.52)(0.85)
EPS (Diluted)(0.28)(3.67)(4.42)(1.52)(0.85)
Weighted Avg Shares22.49M22.85M23.18M23.65M27.18M
Weighted Avg Shares (Diluted)22.49M22.85M23.18M23.65M27.18M

INGN Earnings Waterfall · TTM

NASDAQ:INGN · Revenue to Net Income

Key Ratios

EPS$-0.91
Gross Margin48.8%
Net Margin-7.2%
P/E Ratio-8.3
P/S Ratio2.2

Analysis

$351.5M of revenue converted into -$24.9M of net income for the selected period. Gross margin is 48.8% and net margin is -7.2%, showing how much revenue survives after costs and taxes. EPS is $-0.91, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 9, 2026
8-KCurrent reportNov 5, 2026
8-KCurrent reportSep 30, 2026
4Statement of changes in beneficial ownershipSep 3, 2026
4Statement of changes in beneficial ownershipSep 3, 2026

How much revenue does INGN generate?

Inogen, Inc. (INGN) reported $348.67M of revenue in fiscal 2025.

Is INGN profitable?

Inogen, Inc. (INGN) reported -$22.75M of net income, with a net margin of -6.5%.